Researchers at the University of Cambridge have developed the world's first vaccine whose key component was designed entirely by AI, now entering human trials. The vaccine targets all coronaviruses, including future variants and potential pandemic threats from animals.
Researchers at the University of Cambridge have developed a vaccine whose key antigen was designed entirely by AI, targeting all coronaviruses including future variants and animal-origin threats. It is the first such vaccine to enter human trials, with similar approaches being explored for flu and Ebola.
Traditional vaccines are based on current virus strains, often lagging behind rapid mutations. By analyzing genetic codes of multiple coronaviruses, the AI designed a 'super-antigen' that trains the immune system against the entire virus family, even as they mutate or jump species.
This marks the first time AI has been used to design a vaccine component that has reached human trials, potentially revolutionizing pandemic preparedness. However, it remains in early stages and requires further clinical validation.
Although the article claims it is the 'world's first vaccine designed by AI,' commenters criticize this as an exaggeration, noting that AI has been used in the medical field for decades and that the paper only used basic bioinformatics methods. Meanwhile, some sarcastic comments suggest that 'AI advocates should be the first to get vaccinated.'